MEDICOX Co., Ltd. (KOSDAQ: 054180)
South Korea
· Delayed Price · Currency is KRW 330.00
-9.00 (-2.65%)
Nov 15, 2024, 9:00 AM KST
MEDICOX Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 28,921 | 26,875 | 20,296 | 17,449 | 16,190 | 22,103 | Upgrade
|
| Other Revenue | -0 | - | - | - | - | -0 | Upgrade
|
| Revenue | 28,921 | 26,875 | 20,296 | 17,449 | 16,190 | 22,103 | Upgrade
|
| Revenue Growth (YoY) | 26.13% | 32.42% | 16.32% | 7.78% | -26.75% | -12.38% | Upgrade
|
| Cost of Revenue | 27,457 | 25,022 | 19,801 | 17,015 | 14,095 | 18,188 | Upgrade
|
| Gross Profit | 1,464 | 1,853 | 494.97 | 433.65 | 2,095 | 3,915 | Upgrade
|
| Selling, General & Admin | 12,050 | 10,776 | 10,532 | 8,927 | 5,984 | 4,701 | Upgrade
|
| Research & Development | 2.4 | 2.4 | 2.4 | 2.4 | 1.8 | - | Upgrade
|
| Other Operating Expenses | 45.11 | 81.13 | 53.56 | 47.84 | 122.88 | 43.83 | Upgrade
|
| Operating Expenses | 16,062 | 14,764 | 14,368 | 10,621 | 6,855 | 5,755 | Upgrade
|
| Operating Income | -14,597 | -12,911 | -13,873 | -10,187 | -4,759 | -1,840 | Upgrade
|
| Interest Expense | -3,175 | -3,948 | -2,680 | -3,586 | -1,849 | -1,251 | Upgrade
|
| Interest & Investment Income | 377.34 | 473.77 | 278.31 | 83.59 | 28.24 | 43.81 | Upgrade
|
| Earnings From Equity Investments | -2,253 | -2,352 | 52.84 | -1,605 | -265.44 | -673.55 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.43 | -0.39 | -1.15 | -0.19 | 0.15 | -0.31 | Upgrade
|
| Other Non Operating Income (Expenses) | 3,215 | 502.45 | -14,301 | -966.08 | -194.03 | -31.45 | Upgrade
|
| EBT Excluding Unusual Items | -16,434 | -18,236 | -30,524 | -16,261 | -7,039 | -3,753 | Upgrade
|
| Gain (Loss) on Sale of Investments | -11,470 | -11,837 | -8,923 | -7,663 | -1,374 | -5.49 | Upgrade
|
| Gain (Loss) on Sale of Assets | 931.64 | 967.91 | 3.83 | 10.47 | 46.94 | 66.27 | Upgrade
|
| Asset Writedown | -43.28 | -43.28 | -4,292 | - | - | -227.51 | Upgrade
|
| Other Unusual Items | -328.27 | 45.06 | 1,931 | -24.03 | -216.35 | 37.88 | Upgrade
|
| Pretax Income | -27,344 | -29,104 | -41,804 | -23,938 | -8,583 | -3,882 | Upgrade
|
| Income Tax Expense | - | - | - | - | - | 102.96 | Upgrade
|
| Earnings From Continuing Operations | -27,344 | -29,104 | -41,804 | -23,938 | -8,583 | -3,985 | Upgrade
|
| Earnings From Discontinued Operations | -2,334 | -3,274 | -814.32 | - | - | - | Upgrade
|
| Net Income to Company | -29,678 | -32,378 | -42,619 | -23,938 | -8,583 | -3,985 | Upgrade
|
| Minority Interest in Earnings | - | - | - | 3.15 | - | 389.23 | Upgrade
|
| Net Income | -29,678 | -32,378 | -42,619 | -23,935 | -8,583 | -3,595 | Upgrade
|
| Net Income to Common | -29,678 | -32,378 | -42,619 | -23,935 | -8,583 | -3,595 | Upgrade
|
| Shares Outstanding (Basic) | 44 | 29 | 21 | 13 | 7 | 5 | Upgrade
|
| Shares Outstanding (Diluted) | 44 | 29 | 21 | 13 | 7 | 5 | Upgrade
|
| Shares Change (YoY) | 74.66% | 37.19% | 59.58% | 90.89% | 30.01% | 6.00% | Upgrade
|
| EPS (Basic) | -679.47 | -1117.42 | -2017.83 | -1808.37 | -1237.86 | -674.14 | Upgrade
|
| EPS (Diluted) | -679.47 | -1117.42 | -2017.83 | -1808.37 | -1240.00 | -675.73 | Upgrade
|
| Free Cash Flow | -11,187 | -9,340 | -12,855 | -8,807 | -5,755 | -3,446 | Upgrade
|
| Free Cash Flow Per Share | -256.12 | -322.32 | -608.66 | -665.39 | -829.97 | -646.20 | Upgrade
|
| Gross Margin | 5.06% | 6.90% | 2.44% | 2.49% | 12.94% | 17.71% | Upgrade
|
| Operating Margin | -50.47% | -48.04% | -68.35% | -58.38% | -29.40% | -8.33% | Upgrade
|
| Profit Margin | -102.62% | -120.48% | -209.99% | -137.17% | -53.01% | -16.27% | Upgrade
|
| Free Cash Flow Margin | -38.68% | -34.75% | -63.34% | -50.47% | -35.54% | -15.59% | Upgrade
|
| EBITDA | -12,024 | -9,940 | -10,602 | -7,978 | -2,960 | -396.98 | Upgrade
|
| EBITDA Margin | -41.58% | -36.99% | -52.24% | -45.72% | -18.28% | -1.80% | Upgrade
|
| D&A For EBITDA | 2,573 | 2,971 | 3,272 | 2,209 | 1,800 | 1,443 | Upgrade
|
| EBIT | -14,597 | -12,911 | -13,873 | -10,187 | -4,759 | -1,840 | Upgrade
|
| EBIT Margin | -50.47% | -48.04% | -68.35% | -58.38% | -29.40% | -8.33% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.